MLN4924 shows promise for inhibiting melanogenesis, study reveals
A drug already celebrated in cancer research circles for its ability to sabotage a cellular tagging system has now revealed...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
A drug already celebrated in cancer research circles for its ability to sabotage a cellular tagging system has now revealed...
Scientists are proposing a new way to think about why cancer immunotherapy works for some patients and fails for others,...
Precision oncology has long promised a future in which each patient's tumor is read like a molecular instruction manual, with...
Thyroid cancer is often described as one of the most treatable malignancies, with most differentiated tumors responding well to surgery...
In advanced breast cancer, few clinical situations are as ominous as visceral crisis — the rapid, life-threatening spread of disease...
In one of the largest analyses of tumor genetics ever assembled, an international team of researchers has shown that the...
Multidisciplinary team meetings, or MDTMs, have become the backbone of modern breast cancer care, bringing surgeons, medical oncologists, radiation oncologists,...
Prostate cancer remains one of the most common malignancies affecting men worldwide, and while many cases are slow-growing and manageable,...
Oesophageal cancer is among the most nutritionally punishing malignancies a patient can face. The tumour itself, typically located in the...
Digital health technologies are no longer simply an add-on to traditional cancer prevention programs. According to a new commentary published...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine